Virginia Retirement Systems’s Pacira BioSciences PCRX Stock Holding History

Virginia Retirement Systems’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$851K	Buy	33,550 +6,300	+23%	+$149K	0.01%	808
2026 Q1	$616K	Sell	27,250 -10,900	-29%	-$242K	﹤0.01%	714
2025 Q4	$987K	Sell	38,150 -16,650	-30%	-$396K	0.01%	584
2025 Q3	$1.41M	Buy	54,800 +23,700	+76%	+$582K	0.01%	496
2025 Q2	$743K	Buy	31,100 +1,900	+7%	+$47.9K	0.01%	657
2025 Q1	$726K	Buy	+29,200	New	+$699K	0.01%	650
2023 Q3	–	Sell	-7,400	Closed	-$297K	–	1008
2023 Q2	$297K	Buy	+7,400	New	+$306K	﹤0.01%	841
2021 Q4	–	Sell	-6,800	Closed	-$381K	–	1145
2021 Q3	$381K	Sell	6,800 -700	-9%	-$40.3K	﹤0.01%	837
2021 Q2	$455K	Hold	7,500	–	–	﹤0.01%	844
2021 Q1	$526K	Buy	7,500 +200	+3%	+$14.3K	0.01%	869
2020 Q4	$437K	Buy	7,300 +1,800	+33%	+$105K	﹤0.01%	889
2020 Q3	$331K	Buy	+5,500	New	+$320K	﹤0.01%	902
2019 Q3	–	Sell	-6,500	Closed	-$283K	–	1172
2019 Q2	$283K	Hold	6,500	–	–	﹤0.01%	1038
2019 Q1	$247K	Buy	+6,500	New	+$254K	﹤0.01%	1016

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virginia Retirement Systems's PCRX Position: Q2 2026 in Review

Virginia Retirement Systems increased its Pacira BioSciences (PCRX) stake by 23% in Q2 2026, buying an estimated $149K and bringing the position to 33,550 shares worth $851K. The position accounts for 0.01% of the portfolio, ranked #808.

Virginia Retirement Systems first reported a position in PCRX in Q1 2019 and has held it in 14 quarters since. The position peaked at $1.41M in Q3 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Virginia Retirement Systems held 33,550 shares of Pacira BioSciences worth $851K as of Q2 2026.
Virginia Retirement Systems bought 6,300 Pacira BioSciences shares in Q2 2026, an estimated $149K.
Pacira BioSciences made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #808 holding.
Virginia Retirement Systems first reported a position in Pacira BioSciences in Q1 2019 and has held it in 14 quarters since.
Virginia Retirement Systems's Pacira BioSciences position peaked at $1.41M in Q3 2025.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.